BayMedica Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Employees
-
9
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$3.81M
BayMedica General Information
Description
Developer of a biosynthetic platform designed to provide a portfolio of natural cannabinoids for the life science industry. The company's platform focus on biopharmaceuticals that are made of both naturally occurring and novel pharmaceutical-grade cannabinoids, enabling pharmaceutical manufacturers with an effective alternative to that plant-derived cannabinoids.
Contact Information
Website
www.baymedica.com(Operating Subsidiary)
Corporate Office
- 815 West Hastings Street
- Suite 310
- Vancouver, British Columbia V6C 1B4
- Canada
Corporate Office
- 815 West Hastings Street
- Suite 310
- Vancouver, British Columbia V6C 1B4
- Canada
BayMedica Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 13-Oct-2021 | $3.81M | Completed | Generating Revenue | ||
| 1. Early Stage VC | 01-Sep-2019 | Completed | Generating Revenue |
BayMedica Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
BayMedica Patents
BayMedica Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3205947-A1 | Acyl activating enzymes for preparation of cannabinoids | Pending | 20-Jan-2021 | ||
| EP-4281553-A1 | Acyl activating enzymes for preparation of cannabinoids | Inactive | 20-Jan-2021 | ||
| EP-4281553-A4 | Acyl activating enzymes for preparation of cannabinoids | Inactive | 20-Jan-2021 | ||
| US-20240117388-A1 | Acyl activating enzymes for preparation of cannabinoids | Pending | 20-Jan-2021 | ||
| WO-2022159589-A1 | Acyl activating enzymes for preparation of cannabinoids | Inactive | 20-Jan-2021 | C12N15/81 |
BayMedica Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
BayMedica Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Canna Angels | Angel Group | Minority | ||
| Xandex Ventures | Corporate Venture Capital | Minority |
BayMedica FAQs
-
When was BayMedica founded?
BayMedica was founded in 2016.
-
Where is BayMedica headquartered?
BayMedica is headquartered in Vancouver, Canada.
-
What is the size of BayMedica?
BayMedica has 9 total employees.
-
What industry is BayMedica in?
BayMedica’s primary industry is Multi-line Chemicals.
-
Is BayMedica a private or public company?
BayMedica is a Private company.
-
What is the current valuation of BayMedica?
The current valuation of BayMedica is .
-
What is BayMedica’s current revenue?
The current revenue for BayMedica is .
-
Who are BayMedica’s investors?
Canna Angels and Xandex Ventures have invested in BayMedica.
-
When was BayMedica acquired?
BayMedica was acquired on 13-Oct-2021.
-
Who acquired BayMedica?
BayMedica was acquired by InMed Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
